AI assistant
Sending…
Instil Bio, Inc. — Director's Dealing 2024
Sep 23, 2024
33728_dirs_2024-09-23_a0f5c772-686d-4e79-8436-0e3f2c9fa432.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2024-09-18
Reporting Person: Laumas Sandeep (CFO and CBO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-18 | Employee Stock Option (right to buy) | $66.10 | A | 45000 | Acquired | 2034-09-17 | Common Stock (45000) | Direct |
Footnotes
F1: Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
More from Instil Bio, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 27
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Feb 9
Regulatory Filings
2026
Jan 6
Interim / Quarterly Report
2025
Nov 13